This Industry Report “Global Endometrial Cancer Market Research Report 2018”provides detailed insight covering all important parameters including Development Trends, Challenges, Opportunities, Key Manufacturers and Competitive Analysis.
Endometrial Cancer Market – Overview
The global endometrial cancer market is expecting a robust CAGR and a strong market presence during the forecast period (2018-2023), in an all-inclusive study asserts Market Research Future (MRFR).
Endometrial cancer is also known as uterine cancer and is the sixth most common cancer in women across the world. The daunting number speaks for itself and promotes the factors that ensure the market growth for endometrial cancer.
GET FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/6226
Endometrial Cancer Market -Drivers and Restraints
Urbanization across the world is experiencing an express speed growth rate owing to which the population is undergoing remarkable lifestyle change. A sedentary lifestyle has become the norm for many, and growing obesity among women is resulting in the rising number of endometrial cancer.
Lack of nutritional elements in consumed food and other diseases such as polycystic ovarian syndrome (PCOS) and the ovarian tumor can trigger endometrial cancer.
Endometrial Cancer Market -Dashboard
The market is witnessing significant funding going into research and developments. For instance, Salk Institutes is getting a sizeable amount of fund from Padres Pedal the Cause.
Others are mainly focusing on mergers and acquisitions. Royal Philips acquiring EPD Solutions can be taken exemplary. Boston Scientific has also acquired EMcision, Ltd.
The prominent players involved in the market are
- Pfizer Inc.
- General Electric Company
- Koninklijke Philips N.V.
- LUPIN
- PHYTON
- Bayer AG
- Celgene Corporation
- Johnson & Johnson
- CooperSurgical Inc.
- LiNA Medical USA
- Conceptus Inc.
- Hologic Inc.
- Karl Storz GmbH & Co. Kg
- Boston Scientific Corporation
Obtain Report Details with TOC @ https://www.marketresearchfuture.com/reports/endometrial-cancer-market-6226
Endometrial Cancer Market -Industry Trends
According to the Journal of Clinical Oncology, researchers of John Hopkins Medicine have found a new way to treat uterine cancer by adding the drug trastuzumab to the chemotherapy regimen of the uterine cancer patients.
PapSEEK is a type of liquid biopsy which is now enabling researchers to identify endometrial cancer at a very early stage. The screening procedure is still in its early stage, but it can surely benefit the doctors in diagnosing and treating their patients.
Endometrial Cancer Market -Segmentation
The global endometrial cancer market can be segmented by diagnosis, treatment, and end-user.By diagnosis, the market can further be segmented into the pelvic examination, transvaginal ultrasound, endometrial biopsy, dilation and curettage (D&C), and laparoscopy.
Treatment-based market includes hysterectomy techniques, radiation, hormone therapy, chemotherapy, and palliative care. Based on the end-users the market can be segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, feminist health centers, and others.
Endometrial Cancer Market -Regional Analysis
Region-wise the global endometrial cancer market covers the Americas, Europe, Asia-Pacific (APAC), and the Middle East and Africa (MEA).The Americas are currently holding the largest market share and can continue to do so in the near future.
The region has a well-structured healthcare system and extensive research units who are also contributing significantly to the regional market.
Europe is currently holding the second position in the market. Robust healthcare sector and advanced technologies are supporting the European market for uterine cancer treatment.The APAC can also witness significant growth in the market owing to rising incidence of cervical cancer in countries such as India and China.
FOR EXCLUSIVE DISCOUNT @ https://www.marketresearchfuture.com/check-discount/6226
Some Points form Table of Content of Global Endometrial Cancer Market
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
..TOC Continued
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Your information will never be shared with any third party.